Drug Shortage Report for MYLAN-HYDROXYUREA
| Report ID | 100921 |
| Drug Identification Number | 02242920 |
| Brand name | MYLAN-HYDROXYUREA |
| Common or Proper name | HYDROXYUREA |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROXYUREA |
| Strength(s) | 500MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-29 |
| Estimated end date | 2020-06-02 |
| Actual end date | 2020-06-02 |
| Shortage status | Resolved |
| Updated date | 2020-06-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.